Literature DB >> 33579030

Mechanisms of the Procognitive Effects of Xanthotoxin and Umbelliferone on LPS-Induced Amnesia in Mice.

Łukasz Kurach1, Sylwia Kulczycka-Mamona2, Joanna Kowalczyk2, Krystyna Skalicka-Woźniak3, Anna Boguszewska-Czubara4, Nesrine El Sayed5, Mitat Osmani6, Karol Iwaniak2, Barbara Budzyńska1.   

Abstract

Neuroinflammation plays an essential role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease. Although coumarins have been shown to improve cognitive function in animal models and exert anti-inflammatory effects in cell cultures, the exact mechanism of their neuroprotective effects has not yet been fully elucidated. The present study aimed to investigate the neuroprotective effects of xanthotoxin (furanocoumarin) and umbelliferone (simple coumarin) in lipopolysaccharide-induced cognitive dysfunction in mice. For evaluation memory and learning processes, a passive avoidance test was used. Furthermore, acetylcholinesterase level and impact on the tumor necrosis factor α, interleukin 10 levels in the whole brain, and cyclooxygenase-II in hippocampus was established. Subchronic administration of both coumarins (15 mg/kg) enhanced the learning and memory function, but only the xanthotoxin improved cognitive processes impaired by lipopolysaccharide (0.8 mg/kg) administration. Behavioral results stay in line with acetylcholinesterase level in the brain. A statistically significant decrease in the level of tumor necrosis factor α and cyclooxygenase-II in lipopolysaccharide-treated rodents after coumarins' administration was observed. Together, our findings demonstrate that both coumarins improved cognitive functions, but only xanthotoxin significantly enhanced the learning and memory function and reduced the level of acetylcholinesterase in lipopolysaccharide-treated mice. This effect may suggest that only furanocoumarin-xanthotoxin attenuates neuroinflammation and enhances cholinergic neurotransmission, thus it can be a potential remedy with procognitive potential effective in treatment of neuroinflammatory disease.

Entities:  

Keywords:  coumarins; memory impairment; neuroinflammation

Mesh:

Substances:

Year:  2021        PMID: 33579030      PMCID: PMC7916770          DOI: 10.3390/ijms22041779

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  53 in total

1.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

2.  Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells.

Authors:  Kumiko Tanabe; Rie Matsushima-Nishiwaki; Shinobu Yamaguchi; Hiroki Iida; Shuji Dohi; Osamu Kozawa
Journal:  J Neuroinflammation       Date:  2010-03-06       Impact factor: 8.322

3.  Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity.

Authors:  Ilkay Orhan; Fatma Tosun; Bilge Sener
Journal:  Z Naturforsch C J Biosci       Date:  2008 May-Jun

4.  Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains.

Authors:  Y Kitamura; S Shimohama; H Koike; J i Kakimura; Y Matsuoka; Y Nomura; P J Gebicke-Haerter; T Taniguchi
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

5.  Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress.

Authors:  Puchchakayala Goverdhan; Akina Sravanthi; Thati Mamatha
Journal:  Int J Alzheimers Dis       Date:  2012-03-22

6.  Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.

Authors:  Yan Zhu; Xiao Chen; Zhan Liu; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Int J Mol Sci       Date:  2015-12-28       Impact factor: 5.923

Review 7.  Balancing the immune response in the brain: IL-10 and its regulation.

Authors:  Diogo Lobo-Silva; Guilhermina M Carriche; A Gil Castro; Susana Roque; Margarida Saraiva
Journal:  J Neuroinflammation       Date:  2016-11-24       Impact factor: 8.322

8.  Molecular Docking Studies of Coumarins Isolated from Extracts and Essential Oils of Zosima absinthifolia Link as Potential Inhibitors for Alzheimer's Disease.

Authors:  Songul Karakaya; Mehmet Koca; Serdar Volkan Yılmaz; Kadir Yıldırım; Nur Münevver Pınar; Betül Demirci; Marian Brestic; Oksana Sytar
Journal:  Molecules       Date:  2019-02-17       Impact factor: 4.411

9.  Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice.

Authors:  Jiayi Zhao; Wei Bi; Shu Xiao; Xin Lan; Xiaofeng Cheng; Jiawei Zhang; Daxiang Lu; Wei Wei; Yanping Wang; Hongmei Li; Yongmei Fu; Lihong Zhu
Journal:  Sci Rep       Date:  2019-04-08       Impact factor: 4.379

Review 10.  The cingulate cortex and limbic systems for emotion, action, and memory.

Authors:  Edmund T Rolls
Journal:  Brain Struct Funct       Date:  2019-08-26       Impact factor: 3.270

View more
  3 in total

1.  Neuropsychopharmacological profiling of scoparone in mice.

Authors:  Joanna Kowalczyk; Barbara Budzyńska; Łukasz Kurach; Daniele Pellegata; Nesrine S El Sayed; Jürg Gertsch; Krystyna Skalicka-Woźniak
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

2.  Influence of Umbelliferone on the Anticonvulsant and Neuroprotective Activity of Selected Antiepileptic Drugs: An In Vivo and In Vitro Study.

Authors:  Mirosław Zagaja; Anna Zagaja; Joanna Szala-Rycaj; Aleksandra Szewczyk; Marta Kinga Lemieszek; Grzegorz Raszewski; Marta Andres-Mach
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

3.  Bioactive Diterpenes, Norditerpenes, and Sesquiterpenes from a Formosan Soft Coral Cespitularia sp.

Authors:  You-Cheng Lin; Chi-Chien Lin; Yi-Chia Chu; Chung-Wei Fu; Jyh-Horng Sheu
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.